[HTML][HTML] Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
…, JL Harousseau, B Coiffier, P Biron… - … England Journal of …, 1995 - Mass Medical Soc
Background High-dose chemotherapy followed by autologous bone marrow transplantation
is a therapeutic option for patients with chemotherapy-sensitive non-Hodgkin's lymphoma …
is a therapeutic option for patients with chemotherapy-sensitive non-Hodgkin's lymphoma …
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non …
…, A Bosly, C Anderson, R Schots, P Biron… - … England Journal of …, 1987 - Mass Medical Soc
Adult patients with advanced non-Hodgkin's lymphoma in whom conventional chemotherapy
has failed are seldom cured thereafter. We studied 100 such patients with intermediate-…
has failed are seldom cured thereafter. We studied 100 such patients with intermediate-…
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
…, A Le Cesne, I Judson, O Tredan, J Verweij, P Biron… - Cancer research, 2009 - AACR
Lymphopenia is frequent in advanced cancers and predicts the toxicity of chemotherapy. Its
effect on relapse and survival is uncertain. Its prognostic value for survival was analyzed in …
effect on relapse and survival is uncertain. Its prognostic value for survival was analyzed in …
Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma
E Voog, P Biron, JP Martin, JY Blay - Cancer, 1999 - Wiley Online Library
BACKGROUND Merkel cell carcinoma (MCC) is a highly malignant skin neoplasm. Regional
lymph node and distant metastasis occur in 20–52% of patients. The role of chemotherapy …
lymph node and distant metastasis occur in 20–52% of patients. The role of chemotherapy …
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
…, E Baumelou, F Chauvin, P Biron - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE The impact of treatment options on survival and late neurologic toxicity was
investigated in a series of patients with primary cerebral lymphoma (PCL) and no known cause of …
investigated in a series of patients with primary cerebral lymphoma (PCL) and no known cause of …
The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial
…, C Sebban, T Bachelot, P Biron… - Blood, The Journal …, 1998 - ashpublications.org
The objectives of the present study were to investigate the prognostic value of the International
Prognostic Index (IPI) at relapse in the 215 patients with intermediate- or high-grade non-…
Prognostic Index (IPI) at relapse in the 215 patients with intermediate- or high-grade non-…
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor
JY Blay, N Burdin, F Rousset, G Lenoir, P Biron… - 1993 - ashpublications.org
Serum interleukin-10 (IL-10) was measured retrospectively in 153 patients with a fully
documented history of non-Hodgkin's lymphoma (NHL) using an enzyme-linked immunosorbent …
documented history of non-Hodgkin's lymphoma (NHL) using an enzyme-linked immunosorbent …
[HTML][HTML] Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma
Purpose We examined the utility of post-therapy surveillance imaging in a large, prospectively
enrolled cohort of patients with diffuse large B-cell lymphoma (DLBCL) from the United …
enrolled cohort of patients with diffuse large B-cell lymphoma (DLBCL) from the United …
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective …
…, C Nouvel, H Tilly, P Lederlin, P Biron… - Journal of Clinical …, 1997 - ascopubs.org
PURPOSE To update the randomized study that compared consolidative sequential treatment
(ifosfamide, etoposide, asporaginase, and cytarabine) versus the high-dose regimen of …
(ifosfamide, etoposide, asporaginase, and cytarabine) versus the high-dose regimen of …
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study
…, J Fleury, N Milpied, G Nedellec, P Biron… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: To determine the prognostic factors and outcome of first-line induction failure
Hodgkin's disease patients who were treated with a salvage regimen of high-dose …
Hodgkin's disease patients who were treated with a salvage regimen of high-dose …